Campbell & CO Investment Adviser LLC Immatics N.V. Transaction History
Campbell & CO Investment Adviser LLC
- $1.3 Billion
- Q3 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Immatics N.V. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 14,798 shares of IMTX stock, worth $80,945. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,798Holding current value
$80,945% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding IMTX
# of Institutions
100Shares Held
75.9MCall Options Held
238KPut Options Held
727K-
Rtw Investments, LP New York, NY10MShares$54.7 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$53 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$44.2 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$40.4 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$35.2 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $417M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...